|
WDR26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.581500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.208900E-04 |
| Normal-vs-Stage2 |
4.999800E-01 |
| Normal-vs-Stage3 |
2.703300E-03 |
| Normal-vs-Stage4 |
4.186100E-04 |
| Stage1-vs-Stage2 |
1.023440E-01 |
| Stage1-vs-Stage3 |
7.889800E-01 |
| Stage1-vs-Stage4 |
1.198220E-01 |
| Stage2-vs-Stage3 |
9.952300E-02 |
| Stage2-vs-Stage4 |
1.553600E-02 |
| Stage3-vs-Stage4 |
2.251000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.370100E-04 |
| Normal-vs-AfricanAmerican |
7.207500E-04 |
| Normal-vs-Asian |
4.695100E-03 |
| Caucasian-vs-AfricanAmerican |
1.648450E-02 |
| Caucasian-vs-Asian |
7.673800E-01 |
| AfricanAmerican-vs-Asian |
6.060300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.179200E-03 |
| Normal-vs-Female |
2.192100E-04 |
| Male-vs-Female |
4.998800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.559400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.643600E-03 |
| Normal-vs-Age(61-80Yrs) |
7.798300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.936600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.313200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.897800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.083800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.331200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.460600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.943000E-01 |
| Classical-VS-Follicular |
1.00550012760436E-10 |
| Classical-VS-Other |
1.199240E-01 |
| Classical-VS-Normal |
1.94019999955053E-07 |
| Tall-VS-Follicular |
2.815900E-03 |
| Tall-VS-Other |
2.439000E-01 |
| Tall-VS-Normal |
1.315640E-02 |
| Follicular-VS-Other |
5.435000E-01 |
| Follicular-VS-Normal |
2.567600E-01 |
| Other-VS-Normal |
8.418600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.927780E-01 |
| Normal-vs-N1 |
6.703100E-03 |
| N0-vs-N1 |
4.576400E-02 |
|
|
